Young Irish scientists are heading for the stars as one is to have an asteroid named after him and six others are about to present a project to leading space engineers.

Swiss company Roche said US tax cuts will boost profit this year, blunting the impact of competition to the company’s top-selling cancer medicines, and joining rival Pfizer which has reported a boost from US President Donald Trump’s tax overhaul.

The decade that never really went away is back with a bang, says Kya deLongchamps.

The company planning to build a 240,000-tonne capacity incinerator in Cork Harbour has grossly underestimated the risk zone around its chimney stack, local campaigners have claimed.

A run of disappointing drug trials at Roche has left analysts suggesting the view from its new 41-storey office building in Basel, Switzerland, has become more clouded, with little chance of management now upgrading its growth forecast next week, when it reports first-half earnings.

A drug described as a landmark in treating multiple sclerosis is being reviewed for use in Europe. Trials suggest that Ocrelizumab can slow damage to the brain in two forms of MS, which offers a lot of hope for the future.

The controversial anti- malarial drug Lariam has been withdrawn from sale in the Irish market.

The IDA is likely to renew its push for more resources, to help it accentuate its promotion of Ireland as an investment location, when it formally meets Jobs and Enterprise Minister Mary Mitchell-O’Connor in the coming weeks to review its strategy and performance.

ALL OF the headlines mentioned a “breakthrough”, but there wasn’t one at all. The story first appeared in the Irish Times on Wednesday, June 1. “Heart cell breakthrough at NUI Galway”.

The Ministry of Jobs, Enterprise, and Innovation carries with it the dividend of plenty of foreign travel on behalf of the Government.

An experimental drug designed to lower cholesterol may turn out to be an effective weapon against prostate cancer, research has shown.

One drug firm received fees over €225m from the HSE through the executive’s High Tech Drugs and Medicines scheme in 2014, new figures show.

Pre-tax profits at the main Irish unit of pharmaceutical giant Roche last year fell 8% to €10.39m.

The Department of Defence is continuing to prescribe a controversial malaria drug to personnel serving overseas, despite its manufacturers adding yet another health warning to its use.

Switzerland’s companies warned of a plunge in exports, tourist revenues and profits after the country’s central bank scrapped its cap on the Swiss franc, sending the currency soaring up to 30% and crushing their competitiveness in world markets.

European stocks grow at lesser rate

Pfizer dampened investors’ expectations of a renewed bid for AstraZeneca yesterday by signing a major cancer drug deal with Germany’s Merck, reducing the US firm’s need for Astra’s products.

A breast cancer drug has shown "unprecedented" benefits in extending lives in a clinical trial and experts urged its widespread use for women with an aggressive form of the disease.

A breast cancer drug could extend the lives of patients with an advanced form of the disease by almost five years, a study has found.

Roche Holding has agreed to buy US biotech company InterMune Inc for $8.3bn (€6.3bn) in cash, helping the world’s leading maker of cancer drugs expand into the treatment of rare or incurable diseases. 

The Irish arm of pharmaceutical giant, Roche had a reversal of fortunes last year as it returned to profit following a difficult 2012.

Health Minister Leo Varadkar has been called on to intervene with the Irish and EU regulatory authorities with a view to getting a controversial acne drug withdrawn from the market.

Fashion is a fickle mistress. In an industry predicated on newness, timing is crucial to maintaining a profile that is both relevant and exciting; not least for a designer whose name has yet to open any doors. For haute couture specialists, the success rate is riskier still.

Enda might still abandon Mick and Ming

Swiss voters have narrowly backed proposals to reintroduce immigration quotas with the EU, Swiss television reported — a result that calls into question bilateral accords with the EU and could irk multinational companies.

DEFENCE Minister Alan Shatter has been accused of a cover up over allegations arising from the controversial anti-malaria drug Lariam.

A born-again Christian watching a TV documentary on snakes answered a knock at his door only to be headbutted and struck with a samurai sword.

The US Food and Drug Administration has issued a positive review of a breast cancer drug from Roche that may soon be the first pharmaceutical option approved for treating early- stage disease before surgery.

Every time a new wonder drug for treating cancer comes on the market, the hopes of patients seeking a miracle cure are inevitably raised, only to be dashed amid controversy over the exorbitant cost of treatment.

The main Irish unit of Swiss-owned pharma giant Roche last year plunged into the red arising from the costs of abandoning plans to produce a potential new blockbuster drug at its Clare plant.

For all its glitz and glamour, the biggest story of this year’s Cannes Film Festival was a man who took a job in Roche’s Stores to help him with Irish accents.

The Irish Medicines Board (IMB) says it is “aware” of health concerns in Canada linking cancer treatment drug Avastin and a flesh-eating virus.

The Government will today announce the investment of €200m in seven key research projects, directly creating 800 top-level jobs.

FIFTY percent off the first three months of cancer medicine.

Two out of every three swine flu vaccines stockpiled by the State during the 2009 pandemic crisis have finally been written off as unusable by health officials — costing the taxpayer €8m.

The main Irish unit of Swiss-owned pharma giant Roche last year returned to profit after revenues increased by 29.5% to €87.3m.

A 38-year-old man, seeking the withdrawal of a controversial acne drug from the market in Ireland, is taking his campaign to the EU.

A return to what many racing sailors of a certain generation may regard as the glory days of Cork Week is on the cards for the next seven days as the Royal Cork Yacht Club prepares to welcome visitors and friends from near and far.

The loss of patent on Lipitor looks set to cost up to 180 jobs at two Pfizer plants in Cork. Linda Johnson examines the success of the lucrative cholesterol lowering drug

A planned €45 million expansion of Roche’s Irish production plant is in doubt after the pharmaceutical giant abandoned trials for a new potential blockbuster drug.

A near-$30 billion (€22.8bn) bid for Shire could emerge as the standout deal in the European pharmaceutical sector this year, a highlight for bankers in a market otherwise likely to be dominated by bolt-on acquisitions.

Breast cancer experts are hailing what could be some of the biggest advances in more than a decade – two new medicines that significantly delay the time until women with very advanced cases get worse.